Ledger.Open graph →
SEC Form D · filed April 12, 2016

Silverback Therapeutics, Inc

Offering
$60.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BELLEVUE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Peter A. Thompson · Bellevue, WAExec · DirectorMark S. Christianson · Eden Prairie, MNExec · DirectorGene J. Lollis · Lake Placid, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗